Clinical Trial: Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase II Study Assessing the Activity of Valproate Acid Plus Doxorubicin in Refractory or Recurrent Malignant Mesothelioma

Brief Summary: The purpose of this study is to determine the response rate to the combination of doxorubicin and valproate acid in patients with MM failing after at least one previous chemotherapy regimen including platinum derivatives .